Neurocrine Biosciences (NBIX) News Today → Don’t expose yourself to stocks during the week (From DTI) (Ad) Free NBIX Stock Alerts $132.54 -0.69 (-0.52%) (As of 04/18/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineRoman Butler Fullerton & Co. Buys New Holdings in Neurocrine Biosciences, Inc. (NASDAQ:NBIX)marketbeat.com - April 18 at 10:41 AMInsider Selling: Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Insider Sells 19,818 Shares of Stockinsidertrades.com - April 18 at 6:04 AMSentia and Neurocrine extend collaboration on peptide therapeuticsinvesting.com - April 18 at 1:42 AMEric Benevich Sells 19,818 Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Stockmarketbeat.com - April 17 at 6:38 PMWedbush Reaffirms Outperform Rating for Neurocrine Biosciences (NASDAQ:NBIX)marketbeat.com - April 17 at 3:51 PMValidea Detailed Fundamental Analysis - NBIXnasdaq.com - April 17 at 9:25 AM12,617 Shares in Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Bought by HealthInvest Partners ABmarketbeat.com - April 16 at 6:50 PMThe 5 Stocks Most Sold By Insiders This Year (NBIX)insidertrades.com - April 16 at 10:45 AMNxera Pharma Notes Successful Development Progress of Partnered Schizophrenia Candidate NBI-1117568globenewswire.com - April 16 at 2:30 AMLouisiana State Employees Retirement System Invests $3.64 Million in Neurocrine Biosciences, Inc. (NASDAQ:NBIX)marketbeat.com - April 15 at 7:33 AMNeurocrine Biosciences, Inc. (NASDAQ:NBIX) Receives Average Rating of "Moderate Buy" from Analystsamericanbankingnews.com - April 15 at 2:32 AMResearch Analysts Set Expectations for Neurocrine Biosciences, Inc.'s Q1 2024 Earnings (NASDAQ:NBIX)americanbankingnews.com - April 13 at 1:46 AMLeerink Partnrs Comments on Neurocrine Biosciences, Inc.'s Q1 2024 Earnings (NASDAQ:NBIX)marketbeat.com - April 11 at 7:26 AMNeurocrine Biosciences, Inc. (NASDAQ:NBIX) Shares Bought by Allspring Global Investments Holdings LLCmarketbeat.com - April 11 at 6:58 AMNeurocrine Biosciences' (NBIX) Overweight Rating Reaffirmed at Cantor Fitzgeraldamericanbankingnews.com - April 11 at 5:18 AMNeurocrine Biosciences Announces Conference Call and Webcast of First Quarter 2024 Financial Resultsprnewswire.com - April 10 at 4:01 PMNeurocrine Biosciences, Inc. (NASDAQ:NBIX) Shares Sold by Impax Asset Management Group plcmarketbeat.com - April 10 at 10:46 AMCantor Fitzgerald Reaffirms Overweight Rating for Neurocrine Biosciences (NASDAQ:NBIX)marketbeat.com - April 10 at 10:25 AMTobam Lowers Holdings in Neurocrine Biosciences, Inc. (NASDAQ:NBIX)marketbeat.com - April 9 at 11:47 AMNeurocrine begins phase 2 trial for depression druguk.investing.com - April 5 at 4:00 PMNeurocrine Biosciences executive sells shares worth over $37kinvesting.com - April 5 at 4:00 PMChina Universal Asset Management Co. Ltd. Buys 8,860 Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX)marketbeat.com - April 4 at 6:54 PMWells Fargo Reaffirms Their Hold Rating on Neurocrine (NBIX)markets.businessinsider.com - April 3 at 2:38 PMIs Neurocrine Biosciences, Inc.'s (NASDAQ:NBIX) Recent Performance Tethered To Its Attractive Financial Prospects?finance.yahoo.com - April 3 at 2:38 PMNeurocrine Biosciences Announces First-Patient Dosed in Phase 2 Clinical Study Evaluating NBI-1070770 in Adults with Major Depressive Disorderprnewswire.com - April 3 at 8:30 AMNeurocrine Biosciences, Inc. (NASDAQ:NBIX) Stock Holdings Reduced by SG Americas Securities LLCmarketbeat.com - April 1 at 4:22 AMNeurocrine Biosciences Announces Initiation of Phase 1 Clinical Study Evaluating Effects of NBI-1065890, a Second-Generation VMAT2 Inhibitor, in Healthy Adultsfinance.yahoo.com - March 28 at 8:45 AMNeurocrine Biosciences (NASDAQ:NBIX) Shares Down 4.4% marketbeat.com - March 27 at 12:44 PMAssenagon Asset Management S.A. Lowers Holdings in Neurocrine Biosciences, Inc. (NASDAQ:NBIX)marketbeat.com - March 26 at 2:57 PMIngrid Delaet Sells 5,000 Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Stockinsidertrades.com - March 26 at 4:32 AMS&P 500 Giants Lead Five Stocks Near Buy Points With Fed's Powell A Tailwindfinance.yahoo.com - March 23 at 8:27 AMRedhawk Wealth Advisors Inc. Takes $1.25 Million Position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX)marketbeat.com - March 21 at 10:58 PMNeurocrine Biosciences (NASDAQ:NBIX) Sets New 52-Week High Following Analyst Upgrademarketbeat.com - March 21 at 11:51 AMNeurocrine Biosciences (NASDAQ:NBIX) PT Raised to $158.00marketbeat.com - March 20 at 8:21 AMVanguard Group Inc. Sells 10,875 Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX)marketbeat.com - March 20 at 4:56 AMNeurocrine Biosciences, Inc. (NASDAQ:NBIX) Holdings Cut by Deutsche Bank AGmarketbeat.com - March 18 at 4:44 AMNeurocrine Biosciences director sells $5.58m in stockuk.investing.com - March 17 at 10:32 AMNeurocrine Biosciences exec sells shares worth over $420kuk.investing.com - March 17 at 10:32 AMNeurocrine Biosciences director pops Richard F sells $3.26M in stockinvesting.com - March 17 at 10:32 AMDNB Asset Management AS Has $8.68 Million Stock Holdings in Neurocrine Biosciences, Inc. (NASDAQ:NBIX)marketbeat.com - March 17 at 5:57 AMGeorge J. Morrow Sells 40,000 Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Stockinsidertrades.com - March 17 at 4:22 AMDirector Richard Pops Sells 23,200 Shares of Neurocrine Biosciences Inc (NBIX)finance.yahoo.com - March 16 at 8:47 AMNeurocrine Biosciences Inc's Chief Regulatory Officer Ingrid Delaet Sells 3,000 Sharesfinance.yahoo.com - March 16 at 8:47 AMAI Plays HubSpot, Arista Networks Lead Five Stocks Near Buy Points In Classic Basefinance.yahoo.com - March 16 at 8:47 AMWalleye Capital LLC Makes New Investment in Neurocrine Biosciences, Inc. (NASDAQ:NBIX)marketbeat.com - March 16 at 4:53 AMNeurocrine Biosciences, Inc. (NASDAQ:NBIX) Insider Eric Benevich Sells 75,000 Sharesmarketbeat.com - March 15 at 7:48 PMJuncture Wealth Strategies LLC Buys Shares of 8,082 Neurocrine Biosciences, Inc. (NASDAQ:NBIX)marketbeat.com - March 15 at 7:43 PMNeurocrine Biosciences Is Pioneering Therapies for Neurological Disordersfinance.yahoo.com - March 15 at 2:54 PMNBIX Apr 2024 145.000 callfinance.yahoo.com - March 14 at 8:50 AMIn-Depth Examination Of 8 Analyst Recommendations For Neurocrine Biosciencesmarkets.businessinsider.com - March 13 at 8:05 PM Get Neurocrine Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for NBIX and its competitors with MarketBeat's FREE daily newsletter. Email Address Bitcoin Rockets To Record High But Buy THIS Instead (Ad)Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring… >>Click here to find out what it is. NBIX Media Mentions By Week NBIX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NBIX News Sentiment▼0.630.49▲Average Medical News Sentiment NBIX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NBIX Articles This Week▼158▲NBIX Articles Average Week Get Neurocrine Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for NBIX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Repligen News Today Exelixis News Today Halozyme Therapeutics News Today Denali Therapeutics News Today Adaptive Biotechnologies News Today Biogen News Today Bio-Techne News Today Qiagen News Today Vaxcyte News Today BioNTech News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NBIX) was last updated on 4/18/2024 by MarketBeat.com Staff From Our PartnersSHOCKING Crypto Leak…Crypto 101 MediaThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingBiden’s $374B Giveaway Into This SectorDTIBiden replacement revealed?Paradigm PressThe “Perfect Storm” for GoldGold Safe ExchangeThe #1 Crypto for 2024InvestorPlaceDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTop 5 AI Stocks to Buy for 2024Market Moving Trends Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neurocrine Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.